| Literature DB >> 25852735 |
Maria A Landin1, Ståle Nygård2, Maziar G Shabestari3, Eshrat Babaie4, Janne E Reseland3, Harald Osmundsen1.
Abstract
The main objective of this study was to map global gene expression in order to provide information about the populations of mRNA species participating in murine tooth development at 24 h intervals, starting at the 11th embryonic day (E11.5) up to the 7th post-natal day (P7). The levels of RNA species expressed during murine tooth development were mesured using a total of 58 deoxyoligonucleotide microarrays. Microarray data was validated using real-time RT-PCR. Differentially expressed genes (p < 0.05) were subjected to bioinformatic analysis to identify cellular activities significantly associated with these genes. Using ANOVA the microarray data yielded 4362 genes as being differentially expressed from the 11th embryonic day (E11.5) up to 7 days post-natal (P7), 1921 of these being genes without known functions. The remaining 2441 genes were subjected to further statistical analysis using a supervised procedure. Bioinformatic analysis results for each time-point studied suggests that the main molecular functions associated with genes expressed at the early pre-natal stages (E12.5-E18.5) were cell cycle progression, cell morphology, lipid metabolism, cellular growth, proliferation, senescence and apoptosis, whereas most genes expressed at post-natal and secretory stages (P0-P7) were significantly associated with regulation of cell migration, biosynthesis, differentiation, oxidative stress, polarization and cell death. Differentially expressed genes (DE) not described earlier during murine tooth development; Inositol 1, 4, 5-triphosphate receptor 3 (Itpr3), metallothionein 1(Mt1), cyclin-dependent kinase 4 (Cdk4), cathepsin D (Ctsd), keratin complex 2, basic, gene 6a (Krt2-6a), cofilin 1, non-muscle (Cfl1), cyclin 2 (Ccnd2), were verified by real-time RT-PCR.Entities:
Keywords: ITPR3; gene expression; metallothionein 1; microarrays; qPCR; tooth development
Year: 2015 PMID: 25852735 PMCID: PMC4362327 DOI: 10.3389/fgene.2015.00047
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Sequences of deoxyoligonucleotide primers used for real-time RT-PCR assays.
| 5′-ATG CTG CAG GCC TAT GAG GAG-3′ | 5′-TAC AGA CTG CTT GCG GCT CAG-3′ | |
| 5′-CAG GGC TGT GTC TGC AAA G-3′ | 5′-GCT GGG TTG GTC CGA TAC TA-3′ | |
| 5′-GTT TCT AGG CGG CCT GGA TT-3′ | 5′-CAG CTT GAC GGT CCC ATT AC-3′ | |
| 5′-CCA CTG TCA GGG AAC TGG AT-3′ | 5′CTC CTT CAG ACA GGC AGA GG-3′ | |
| 5′-AGG CTG CTG AAG GAG TAC CA-3′ | 5′-TCA ACC TGC ACT CCT CTC CT-3′ | |
| 5′-GGA GGT AAG GGA AGC ACT CC-3′ | 5′-CTC CTC GAT GGT CAA CAG GT-3′ | |
| 5′-TCT ATG CCA GCT CCA AGG AT-3′ | 5′-TCT GGG GCT GTT AAG ATG CT-3′ | |
| 5′-AGG ACC TCG AGG CTC TTC TC-3′ | 5′-CTC CTT CAG CGT CTG TAG CC-3′ | |
| 5′-GGG AAA GTG GTG GTG GTG CT-3′ | 5′-CAC CAG GGC ATG GCT GTA AG-3′ |
The table lists genes, and their corresponding deoxyoligonucleotide primer pairs, used to measure mRNA levels in tooth germs at various time-points using real-time RT-PCR assays. Primers were designed to have melting point 60°C and product size of about 100 bp.
Figure 1Microarray results for for DE genes throughout the time-course. The figure presents results showing the net normalized fluorescence intensities for DE genes monitored using microarrays with SD.
Figure 2RT-PCR results for the time-course. Levels of selected mRNAs in total RNA isolated from the molar tooth germ at the various times of development using real-time RT-PCR.
Bioinformatic results for transcription factor analysis using IPA.
| BIOINFORMATIC RESULTS FOR TRANSCRIPTION FACTOR ANALYSIS (IPA) AT PRE-NATAL DAYS (E12.5–E18.5) | |||
| E12.5 | Atf5 | 1,41E-03 | Expression, apoptosis, G2/M phase transition, growth, differentiation, survival, cell survival |
| C/Ebp | 1,41E-03 | Differentiation, proliferation, expression, apoptosis, adipogenesis, transcription | |
| Cited4 | 8,28E-03 | Unknown | |
| Ctnnb1 | 1,41E-03 | Expression, proliferation, apoptosis, differentiation, transcription, transformation, growth, adhesion, migration | |
| Dnmt3l | 8,28E-03 | Unknown | |
| Dux4 | 1,65E-03 | Unknown | |
| Eaf2 | 8,28E-03 | Apoptosis, growth, stabilization, expression | |
| Hif3a | 1,41E-03 | Transactivation, quantity, activation | |
| Htt | 8,67E-05 | Cell death, apoptosis, expression in, degeneration, quantity, survival, activation | |
| Max-Myc | 8,28E-03 | Unknown | |
| Meox2 | 6,77E-06 | Migration, size, transactivation in, G0/G1 phase transition, binding, activation, angiogenesis, apoptosis | |
| Mdm2 | 1,41E-03 | Apoptosis, cell cycle progression, degradation, proliferation, ubiquitination, expression, growth, G1 phase, differentiation | |
| Mxd3 | 1,41E-03 | Transformation, cell death, expression, differentiation, S phase, proliferation, survival | |
| Mxd4 | 1,41E-03 | Unknown | |
| Siah2 | 8,28E-03 | Apoptosis, degradation, association, activation, differentiation, transmigration, quantity | |
| Sox15 | 1,41E-03 | Unknown | |
| Smad1/5 | 8,18E-03 | Expression, migration | |
| Znf281 | 8,28E-03 | Differentiation | |
| Znf197 | 1,41E-03 | Unknown | |
| Xbp1 | 8,28E-03 | Expression, cell death, production, survival, differentiation, transcription, degradation, endoplasmic reticulum stress response | |
| E13.5 | Drap1 | 2,37E-08 | Assembly |
| Hoxa9 | 2,37E-08 | Expression in, quantity, transformation, proliferation, colony formation, number, differentiation, morphology, apoptosis | |
| Hmga1 | Unknown | ||
| Myc | 3,81E-05 | Apoptosis, proliferation, transformation, growth, cell cycle progression, expression, differentiation, S phase, death | |
| Mxl1 | 1,41E-03 | Proliferation, function, transcription, cell cycle progression, expression, morphology, G2/M phase, S phase | |
| Pparg | 6,77E-06 | Differentiation, expression, adipogenesis, proliferation, apoptosis, growth, transcription, cell cycle progression, cell quantity, cell morphology | |
| Mxi1 | 6,77E-06 | Transformation, proliferation, function, transcription, cell cycle progression, expression, morphology, G2/M phase, S phase | |
| E14.5 | Myc | 8,28E-03 | See E13.5 |
| Mycn | 2,48E-05 | Proliferation, apoptosis, transformation, expression, growth, differentiation, transactivation, transcription, survival | |
| Mxl1 | 1,78E-03 | See E13.5 | |
| Smarcc | 1,60E-02 | Apoptosis, remodeling, disassembly, development, expression, reorganization, binding, stabilization, ubiquitination | |
| E15.5 | Ahr | 5,16E-04 | Apoptosis, cell cycle progression, expression, differentiation, proliferation, quantity, homeostasis, transcription, function |
| Cdkn2a | 4,11E-09 | Proliferation, apoptosis, cell cycle progression, growth, senescence, G1 phase, transformation, S phase, binding | |
| Hmga1 | 2,49E-04 | Unknown | |
| Hoxa10 | 1,41E-03 | Differentiation, proliferation, repression, morphology, development, expansion, G1 phase, mineralization | |
| Mycn | 1,14E-14 | See E14.5 | |
| Tp53 | 2,48E-05 | Apoptosis, cell cycle progression, proliferation, cell death, expression, growth, G1 phase, senescence, survival | |
| E16.5 | Drap1 | 4,11E-09 | See E13.5 |
| Dysf | 2,23E -3 | Repair, morphology, fusion, size, healing, resealing, adhesion, expression | |
| Elavl1 | 2,94E-3 | Translation, expression, number, phosphorylation, sensitivity, proliferation, growth, apoptosis | |
| Epo | 1,71E-4 | Proliferation, differentiation, apoptosis, colony formation, growth, production, survival, quantity, maturation | |
| Hmga1 | 9,84E-15 | Unknown | |
| Hoxa9 | 8,28E-34 | See E13.5 | |
| Hif-1a | 2,37E-08 | Expression, apoptosis, proliferation, activation, transcription, differentiation, growth, cell death, migration | |
| Kras | 7,6E-5 | Apoptosis, transformation, growth, proliferation, expression, morphology, cell death, survival, colony formation | |
| Myc | 5,6E-32 | See E13.5 | |
| Mycn | 2,13E-32 | See E14.5 | |
| Stat6 | 3,33E-17 | Differentiation, proliferation, expression, development, function, quantity, number, polarization, recruitment | |
| Psen1 | 9,6E-5 | Apoptosis, quantity, expression, differentiation, formation, cell death, activation, migration | |
| E17.5 | Drap1 | 6,77E-06 | See E13.5 |
| Hmga1 | 2,02E-07 | Unknown | |
| Hoxd10 | 7,12E-24 | Expression, migration, angiogenesis, polarization, invasion | |
| Tfap2a | 2,58E-12 | migration, growth, expression, apoptosis, cell death, proliferation, development, invasion, differentiation, invasion | |
| Xbp1 | 2,58E-12 | Expression, cell death, survival, differentiation, transcription, degradation, endoplasmic reticulum expansion | |
| Rela | 2,58E-12 | Apoptosis, expression, proliferation, survival, activation, cell death, transactivation, transcription, migration | |
| Arnt | 2,58E-12 | Proliferation, expression, differentiation, migration, growth, apoptosis, G1 phase, glycolysis | |
| E2f1 | 2,58E-12 | Apoptosis, proliferation, cell cycle progression, S phase, expression, G1/S phase transition, G1 phase, growth, cell death, cell quantity | |
| Max | 2,58E-12 | Apoptosis, transformation, growth, proliferation, mitogenesis, cell cycle progression, differentiation, migration, S phase | |
| Myod1 | 2,02E-07 | Differentiation, cell cycle progression, myogenesis, expression, activation, growth, binding, survival, fate determination | |
| Nfkb | 2,02E-07 | Apoptosis, cell survival, proliferation, cell death transcription, differentiation, activation, growth | |
| Stat3 | 2,02E-07 | Proliferation, expression, apoptosis, growth, differentiation, transformation, migration, survival, cell death | |
| E18.5 | Cand1 | 2,02E-07 | Differentiation |
| Hmga1 | 6,77E-06 | Unknown | |
| Hnf1a | 8,19E-06 | Expression, transcription, apoptosis, activation, differentiation, proliferation, transactivation, cell number | |
| Ctnnb1 | 8,19E-06 | Proliferation, apoptosis, differentiation, transcription, transformation, growth, activation, adhesion, migration | |
| Htt | 8,19E-06 | See E12.5 | |
| Myc | 2,58E-12 | See E13.5 | |
| P0 | Myc | 2,83E-24 | See E13.5 |
| Stat6 | 8,05E-12 | See E16.5 | |
| Tfap2a | 1,64E-07 | Migration, growth, expression, apoptosis, cell death, proliferation, development, invasion, differentiation, invasion | |
| Hoxd10 | 4,00E-07 | Expression, migration, angiogenesis, polarization, invasion | |
| Mxl1 | 2,67E-05 | See E13.5 | |
| Foxo1 | 2,64E-07 | Expression, transcription, apoptosis, transactivation, proliferation, activation, differentiation, binding, downregulation, ubiquitination | |
| P1 | Ahr | 6,05E-10 | Apoptosis, cell cycle progression, expression, differentiation, proliferation, quantity, homeostasis, morphology, transcription, function |
| Esrra | 1,00E-07 | Differentiation, expression, number, proliferation, growth, migration, ossification, uptake, glycolysis | |
| Hmga1 | 6,16E-15 | Unknown | |
| Mycn | 2,60E-07 | See E16.5 | |
| P2 | Drap1 | 2,91E-04 | Assembly |
| Hmga1 | 1,61E-05 | Unknown | |
| Myc | 1,13E-27 | See E13.5 | |
| Tfap2a | 2,70E-05 | Migration, growth, expression, apoptosis, cell death, proliferation, development, invasion, differentiation, invasion | |
| P3 | Irf4 | 5,90E-12 | Differentiation, number, proliferation, expression, development, lack, abnormal morphology, function, quantity, apoptosis |
| Nfkb1 | 4,66E-06 | Apoptosis, cell number, proliferation, function, differentiation, quantity, development, expression, cell death, activation | |
| Med30 | 3,64E-05 | Unknown | |
| Mxd1 | 5,48E-05 | Cell transformation, proliferation, apoptosis, S phase, G1 phase, expression in, growth, cell quantity, transcription | |
| Pparg | 7,56E-07 | Differentiation, expression, adipogenesis, proliferation, apoptosis, growth, transcription, cell cycle progression, quantity | |
| Stab1 | 5,80E-07 | Proliferation, expression, differentiation, activation, quantity, organization, recruitment, number, apoptosis, development | |
| Stat3 | 5,31E-07 | proliferation, expression, apoptosis, growth, differentiation, transformation, migration, survival, invasion | |
| Stat6 | 1,34E-11 | See E16.5 | |
| Tp73 | 6,43E-27 | Apoptosis, expression, cell death, growth, cell cycle progression, proliferation, DNA damage response, colony formation, differentiation | |
| Tfap2a | 5,56E-09 | Migration, growth, expression, apoptosis, cell death, proliferation, development, differentiation, invasion | |
| P4 | Esr1 | Expression, growth, proliferation, transcription, transactivation, phosphorylation, apoptosis, invasion, migration, binding | |
| Hmga1 | Unknown | ||
| Irf4 | 1,90E-14 | Differentiation, number, proliferation, expression, development, lack, abnormal morphology, function, quantity, apoptosis | |
| Mycn | 2,38E-11 | See E14.5 | |
| Mxd3 | 1,02E-13 | See E12.5 | |
| Mxd4 | Unknown | ||
| Nfkb | 8,09E-06 | Apoptosis, expression, survival, proliferation, transcription, cell death, activation, differentiation, growth | |
| Nfyc | 3,25E-04 | Expression, binding, transcription | |
| P5 | Myc | 1,92E-17 | See E13.5 |
| Htt | 5,86E-03 | See E12.5 | |
| Mycn | 5,20E-07 | See E14.5 | |
| P6 | Hmga1 | 1,30E-02 | unknown |
| Drap1 | 5,86E-03 | See E13.5 | |
| Nfkb | 1,30E-12 | See P4 | |
| Nrf1 | 9,27E-06 | Apoptosis, organization, oxidative stress response, cell death, proliferation, quantity, cell viability, expression, replication | |
| Mxl1 | 2,85E-03 | See E13.5 | |
| P7 | Hmga1 | 9,27E-06 | Unknown |
| Med30 | 1,13E-05 | Unknown | |
| Stat3 | 2,07E-14 | See P3 | |
| Stat6 | 1,04E-11 | See P3 | |
| SPI1 | 1,89E-11 | Differentiation, number, morphology, proliferation, apoptosis, expression, transcription | |
| Tp73 | 1,74E-25 | See P3 | |
| Tfap2a | 2,32E-11 | See P0 | |
The 2441 differentially expressed genes (DE) (p ≤ 0.05) were used to determine significant associations (p ≤ 0.01) with transcription factors (TF) prior to birth. TFs with p-value of overlap <0.01 where considered to be significantly associated with the DE genes from the dataset.
Abreviations: TF, Transcription factors; embryonic day (E12.5–E18.5).
Figure 3Transcription factor analysis (IPA). Bioinformatics transcription factor analysis performed using Ingenuity Pathway Analysis (IPA) for the 4362 genes throughout the time-course (A–O) exhibiting a p-value of overlap <0.01 associating significantly ~1000 genes with 63 transcription factors. Pre-natal stages: Bud stages [A (E12.5), B (E13.5)]. Enamel knot stage [C (E14.5)]. Bell stages [D (E15.5), E (E16.5), F (E17.5), and G (E18.5)]. Day of birth (P0). Post-natal stages: Differentiation of odontoblasts (I–K), start of mineralization: dentin deposition (N–L), enamel deposition (O).
Biological functions associated with network analysis.
| Amino acid metabolism | – | – | – | – | – | – | x | – | – | – | X | – | – | – | – |
| Carbohydrate metabolism | X | – | – | X | – | – | X | X | X | X | – | X | X | X | – |
| Cell cycle | X | X | X | – | X | X | X | X | X | X | X | X | – | – | X |
| Cell death | – | X | – | – | X | X | X | X | X | X | – | X | X | X | X |
| Cell morphology | – | X | X | X | – | X | X | – | X | – | – | – | X | – | X |
| Cell-to- cell signaling | X | – | X | – | – | – | – | – | X | – | – | X | X | – | – |
| Cellular assembly and organization | – | – | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Cellular compromise | – | X | – | X | – | – | X | X | X | – | X | X | X | X | X |
| Cellular development | X | X | X | X | X | X | X | X | X | X | X | X | – | X | X |
| Cellular function and maintenance | – | – | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Cellular growth and proliferation | X | X | X | X | X | X | X | X | X | X | X | X | – | X | X |
| Cellular movment | X | – | X | X | X | – | X | – | X | – | – | X | X | – | X |
| Connective tissue development | X | – | – | X | – | X | X | X | X | – | X | – | – | X | X |
| DNA replication | – | X | – | X | X | X | X | – | X | X | X | – | – | X | X |
| Embryonic developmemt | – | X | – | – | – | X | – | X | X | X | – | – | – | X | – |
| Energi production | – | X | – | X | X | X | – | X | X | X | X | X | – | X | X |
| Free radical scavenging | – | – | – | – | – | – | – | X | – | X | – | – | – | – | – |
| Gene expresssion | – | X | – | – | X | X | X | X | X | X | X | X | – | X | X |
| Hematological system development | – | – | – | – | – | X | – | – | – | – | – | – | – | – | – |
| Lipid metabolism | – | – | – | – | X | X | – | X | X | X | X | X | – | – | X |
| Molecular transport | – | X | – | – | X | X | X | X | X | X | X | X | X | X | X |
| Nucleic acid metabolism | – | X | – | X | X | X | X | X | X | X | X | X | – | X | X |
| Organ morphology | – | – | – | – | – | – | – | – | X | X | – | – | – | X | X |
| Organismal development | – | – | X | – | – | – | X | – | – | – | – | – | – | – | – |
| Post-transcriptional modification | – | – | X | – | – | – | – | X | X | X | X | X | – | X | X |
| Post-translational modification | – | X | – | – | – | – | X | – | – | – | – | – | – | – | – |
| Proliferation | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Protein degradation | – | – | – | – | – | – | – | X | – | – | – | – | – | – | – |
| Protein degradation | – | X | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Protein folding | – | X | – | – | – | – | – | X | – | – | X | X | – | – | X |
| Protein synthesis | – | X | – | – | X | X | X | X | X | X | X | X | – | X | X |
| Protein trafficking | – | – | – | – | – | X | X | – | – | X | – | X | – | X | X |
| RNA post-transcriptional modification | X | X | – | X | X | X | X | X | X | X | X | – | – | X | – |
| RNA replication | – | – | – | – | – | – | – | – | – | – | – | – | – | X | – |
| Scenescence | – | – | X | – | X | X | X | – | – | – | – | – | – | – | – |
| Skeletal and muscular development | – | – | – | – | – | – | – | – | – | – | – | X | – | – | X |
| Small molecule biochemistry | – | X | – | – | X | X | X | X | X | X | X | X | X | X | X |
| Tissue development | – | X | – | – | X | X | – | X | X | X | X | – | – | – | – |
| Tissue morphology | – | – | X | – | – | X | X | X | – | – | – | – | – | X | – |
| Vitamin and mineral metabolism | – | – | – | – | – | – | – | – | X | – | – | – | – | – | – |
The table shows a summary of the biological functions significantly associated with the networks resulting from bioinformatics time-course network analysis presented as supplementary data.
Figure 4Bioinformatics analysis of the global mRNA transcriptome during murine tooth development using Molecular & Cellular functions (A–F) significantly (.
Canonical pathways.
| E12.5 | Polyamine Regulation | 7,56E-03 | |
| Oxidative Phosphorylation | 8,73E-03 | ||
| Urea Cycle and Metabolism of Amino Groups | 1,38E-02 | ||
| mTOR Signaling | 2,54E-02 | ||
| N-Glycan Biosynthesis | 2,73E-02 | ||
| E13.5 | Oxidative Phosphorylation | 4,19E-34 | |
| EIF2 Signaling | 1,51E-22 | ||
| Ubiquinone Biosynthesis | 8,01E-16 | ||
| mTOR Signaling | 5,21E-09 | ||
| E14.5 | Synaptic Long Term Potentiation | 1,42E-03 | |
| Urea Cycle and Metabolism of Amino Groups | 5,14E-03 | ||
| Pyruvate Metabolism | 8,83E-03 | ||
| Melatonin Signaling | 1,02E-02 | ||
| Insulin Receptor Signaling | |||
| E15.5 | Oxidative Phosphorylation | 1,39E-10 | |
| EIF2 Signaling | 8,45E-08 | ||
| Regulation of Actin-based Motility by Rho | 1,58E-07 | ||
| Integrin Signaling | 1,47E-06 | ||
| E16.5 | Oxidative Phosphorylation | 4,55E-43 | |
| EIF2 Signaling | 8,95E-25 | ||
| Ubiquinone Biosynthesis | 3,72E-17 | ||
| Regulation of eIF4 and p70S6K Signaling | 1,32E-09 | ||
| E17.5 | Oxidative Phosphorylation | 4,55E-43 | |
| EIF2 Signaling | 8,95E-25 | ||
| Ubiquinone Biosynthesis | 3,72E-17 | ||
| Regulation of eIF4 and p70S6K Signaling | 1,32E-09 | ||
| E18.5 | Oxidative Phosphorylation | 1,85E-21 | |
| EIF2 Signaling | 3,95E-19 | ||
| Ubiquinone Biosynthesis | 4,18E-11 | ||
| Regulation of Actin-based Motility by Rho | 1,66E-08 | ||
| P0 | Oxidative Phosphorylation | 1,52E-44 | |
| EIF2 Signaling | 8,13E-30 | ||
| Ubiquinone Biosynthesis | 3,1E-17 | ||
| Regulation of Actin-based Motility by Rho | 4,26E-26 | ||
| Regulation of eIF4 and p70S6K Signaling | 1,75E-13 | ||
| P1 | Oxidative Phosphorylation | 8,39E-31 | |
| Ubiquinone Biosynthesis | 1,39E-10 | ||
| EIF2 Signaling | 4,58E-07 | ||
| Integrin Signaling | 2,56E-05 | ||
| P2 | Oxidative Phosphorylation | 5,12E-40 | |
| EIF2 Signaling | 2,12E-30 | ||
| Ubiquinone Biosynthesis | 8,16E-17 | ||
| Regulation of eIF4 and p70S6K Signaling | 6,71E-12 | ||
| P3 | Oxidative Phosphorylation | 8,64E-46 | |
| EIF2 Signaling | 1,06E-37 | ||
| Ubiquinone Biosynthesis | 3,77E-19 | ||
| Regulation of eIF4 and p70S6K Signaling | 1,41E-16 | ||
| P4 | Oxidative Phosphorylation | 4,28E-35 | |
| Ubiquinone Biosynthesis | 1,66E-12 | ||
| EIF2 Signaling | 7,71E-09 | ||
| Regulation of Actin-based Motility by Rho | 1,97E-05 | ||
| P5 | Oxidative Phosphorylation | 6,17E-07 | |
| Ubiquinone Biosynthesis | 1,04E-03 | ||
| Integrin Signaling | 9,3E-03 | ||
| Lipid Antigen Presentation by CD1 | 2,32E-02 | ||
| Hepatic Stellate Cell Activation | 2,53E-02 | ||
| P6 | Oxidative Phosphorylation | 1,03E-40 | |
| EIF2 Signaling | 3,41E-16 | ||
| Ubiquinone Biosynthesis | 1,37E-15 | ||
| Regulation of eIF4 and p70S6K Signaling | 7,13E-08 | ||
| P7 | Oxidative Phosphorylation | 4,72E-46 | |
| EIF2 Signaling | 9,55E-32 | ||
| Ubiquinone Biosynthesis | 4,23E-18 | ||
| Regulation of eIF4 and p70S6K Signaling | 1,09E-12 |
Signaling or metabolic pathways (IPA) significantly associated with DE genes during murine tooth development.